JAAA acquires Italian pharma manufacturer GiPharmanuary 27th, 2009 – AAA Italy has completed the acquisition of Gipharma , a pharmaceutical contract manufacturer for injectable and freeze-dried products, specialized in radiopharmaceuticals (RP) for SPECT. Gipharma was founded in 2002 and is based in the Saluggia (VC) Technological Park. Thanks to this acquisition, AAA will increase its presence in the SPECT market – which accounts today for the 70% of the global nuclear medicine business and shows positive growth perspectives in the coming years. Gipharma also offers a wide range of custom manufacturing and analytical services under cGMP requirements.